Rik Ossenkoppele
21 – 30 of 178
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment
- Contribution to journal › Article
-
Mark
Plasma Biomarker Strategy for Selecting Patients with Alzheimer Disease for Antiamyloid Immunotherapies
- Contribution to journal › Article
-
Mark
Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease
- Contribution to journal › Article
-
Mark
Cognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns
- Contribution to journal › Article
-
Mark
Rationale and design of the BeyeOMARKER study : prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic
- Contribution to journal › Article
-
Mark
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model
- Contribution to journal › Article
-
Mark
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
- Contribution to journal › Article
-
Mark
Biological mechanisms of resilience to tau pathology in Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Association of in vivo retention of [18f] flortaucipir pet with tau neuropathology in corresponding brain regions
- Contribution to journal › Article
-
Mark
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
- Contribution to journal › Article
